<https://rdf.molmedb.upol.cz/reference/ref1337> <http://purl.org/ontology/bibo/doi> "10.1128/aac.01183-08"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target3>,
		<https://identifiers.org/molmedb/MM00907>;
	<http://purl.org/ontology/bibo/pmid> "19001108"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target97>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Cihlar T, Laflamme G, Fisher R, Carey AC, Vela JE, Mackman R, Ray AS.: Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation. Antimicrob Agents Chemother, Volume 53 (1), 2009"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17186> .
<https://rdf.molmedb.upol.cz/transporter/tra31708> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1337> .
<https://rdf.molmedb.upol.cz/transporter/tra31845> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1337> .
<https://rdf.molmedb.upol.cz/transporter/tra31709> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1337> .